Aeva to Participate in Oppenheimer Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: Yahoo Finance
- Investor Event: Aeva management will participate in the Oppenheimer 11th Annual Emerging Growth Conference on February 3, 2026, providing an opportunity for engagement with institutional investors to enhance the company's visibility and credibility.
- Technological Vision: Aeva aims to accelerate autonomy across various sectors, including automated driving, manufacturing automation, and smart infrastructure, showcasing its leadership in future technologies.
- Product Advantage: Aeva's 4D LiDAR sensors uniquely detect velocity and position simultaneously, enabling automated devices like vehicles and robots to make more intelligent and safer decisions, thereby enhancing competitiveness in the industry.
- Market Positioning: By collaborating with Oppenheimer, Aeva seeks to further solidify its position in the automation and smart device market, attracting more investments to support its technology development and market expansion.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like AEVA with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on AEVA
Wall Street analysts forecast AEVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AEVA is 23.89 USD with a low forecast of 18.55 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 14.400
Low
18.55
Averages
23.89
High
33.00
Current: 14.400
Low
18.55
Averages
23.89
High
33.00
About AEVA
Aeva Technologies, Inc. is engaged in the design, manufacturing and sale of LiDAR sensing systems and related perception and autonomy-enabling software solutions serving customers in automotive, industrial, and other markets. The Company, through its frequency modulated continuous wave (FMCW) sensing technology, enables the adoption of LiDAR across broad applications. Its sensing and perception technology integrates all key LiDAR components onto a silicon photonics chip in a compact module. Its products include Aeries II, is a 4D LiDAR solution, consisting of its 4D LiDAR sensing system with embedded software designed for automotive grade production across passenger car, trucking, and mobility applications; Atlas, is its FMCW 4D LiDAR with simultaneous velocity and range detection targeted for the automotive market, and Atlas Ultra, is a 4D LiDAR sensor built to meet the performance demands of SAE Level 3 and 4 automated driving systems in passenger and commercial vehicles.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aeva to Participate in Oppenheimer Conference
- Investor Event: Aeva management will participate in the Oppenheimer 11th Annual Emerging Growth Conference on February 3, 2026, providing an opportunity for engagement with institutional investors to enhance the company's visibility and credibility.
- Technological Vision: Aeva aims to accelerate autonomy across various sectors, including automated driving, manufacturing automation, and smart infrastructure, showcasing its leadership in future technologies.
- Product Advantage: Aeva's 4D LiDAR sensors uniquely detect velocity and position simultaneously, enabling automated devices like vehicles and robots to make more intelligent and safer decisions, thereby enhancing competitiveness in the industry.
- Market Positioning: By collaborating with Oppenheimer, Aeva seeks to further solidify its position in the automation and smart device market, attracting more investments to support its technology development and market expansion.
Continue Reading
Valneva SE Withdraws Chikungunya Vaccine Applications, Shares Drop 7.7%
- Vaccine Withdrawal: Valneva SE has withdrawn its BLA and IND applications for the IXCHIQ Chikungunya vaccine due to an FDA suspension and review of new serious adverse events, leading to a 7.7% drop in pre-market trading to $9.29, indicating market concerns over its product prospects.
- Market Decline: U.S. stock futures are broadly lower, with Dow futures falling around 700 points, reflecting investor caution regarding economic outlook, which may impact overall market sentiment and exacerbate volatility in other stocks.
- Other Stock Movements: Shares of Rezolve AI PLC and POET Technologies Inc fell 15% and 11.2% respectively in pre-market trading, indicating widespread investor apprehension towards tech stocks, potentially prompting a reassessment of risk appetite.
- Tesla Update: Tesla's stock fell 2.7% to $425.75 in pre-market trading, despite CEO Elon Musk confirming that vehicles equipped with the AI4 chip will achieve unsupervised autonomous driving, suggesting insufficient market confidence in the electric vehicle sector.
Continue Reading